Top Medical News
Christina Lau, Yesterday

Feelings of injustice and low socioeconomic status can have a significant impact on disease severity in patients with fibromyalgia, according to data from a large survey presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

3 days ago
Sleep disorders commonly occur in patients with ankylosing spondylitis (AS), particularly those with high disease activity, a study has found. Furthermore, treatment with antitumour necrosis factor (anti-TNF)-α improves sleep quality but not polysomnography parameters.
Jackey Suen, 4 days ago

The fully-human immunocytokine dekavil (also known as F8-IL10) has demonstrated signs of safety and efficacy in patients with active rheumatoid arthritis (RA) in a phase I study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017.

Dr. Joseph Delano Fule Robles, 4 days ago

Vobarilizumab, a nanobody consisting of an anti-interleukin 6 (IL-6) receptor domain developed for the treatment of rheumatoid arthritis (RA), is shown to be safe and efficacious in RA patients with inadequate response to methotrexate in a study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

4 days ago
Quadriceps isometric contraction exercise may effectively relieve joint pain and improve knee joint function in patients with knee osteoarthritis (OA), according to a study.
5 days ago
Compared with other models of care, nurse-led care (NLC) for patients with rheumatoid arthritis (RA) is effective, acceptable and safe, according to a recent study. However, current evidence is limited to draw conclusions on its accessibility, appropriateness and efficiency.
Elaine Tan, 5 days ago

Women who are overweight or obese, as defined by a high body mass index (BMI), abdominal obesity and a higher body fat percentage, have a higher risk of developing rheumatoid arthritis (RA), results of a Danish population cohort study has shown.

Special Reports
03 Apr 2017
At the International Osteoporosis Foundation Regionals – 6th Asia-Pacific Osteoporosis Meeting in Singapore, Professor Olivier Bruyère shared about the algorithm for the management of knee OA by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). MIMS Doctor also spoke to Professor Jean-Yves Reginster, president of ESCEO about this algorithm and the role of SYSADOAs in the control of pain and prevention of disease progression.
07 Mar 2017
At the 17th Malaysian Society of Rheumatology/Singapore Society of Rheumatology Workshop, Associate Professor Susanna Proudman, a senior consultant in rheumatology from Australia, shared with the audience on the diagnosis and management of pulmonary arterial hypertension (PAH), with a focus on systemic sclerosis (SSc)-related PAH.
18 Aug 2016
During the combined meeting of the 46th Malaysian Orthopaedic Association Annual General Meeting/Annual Scientific Meeting and the 10th ASEAN Arthroplasty Association Meeting, Dr Joseph Pergolizzi spoke on the importance of chronic pain control and appropriate strategies to achieve this. Highlights of his presentation are summarized below.
09 Oct 2015
Calcium and vitamin D play a major role in the prevention and treatment of osteoporosis. In this exclusive interview with MIMS Doctor, Dr Yeap Swan Sim talks about the importance of calcium and vitamin D in bone health, as well as the current status of these micronutrients in local postmenopausal women.
07 Jul 2015

At a recent lunch symposium held in conjunction with the Malaysian Menopause Society Conference 2015, Dr Lee Joon Kiong spoke on the management of osteoporosis in young postmenopausal women. Below are the highlights of his talk.

13 May 2015
Recently, MIMS Doctor sat down with Associate Professor Dr Sabarul Afian Mokhtar to get his perspectives on the use of monoclonal antibody for the treatment of postmenopausal osteoporosis (PO) and also important learning from the International Osteoporosis Foundation (IOF) Regionals 5th Asia-Pacific Osteoporosis Meeting. Highlights from the interview are presented here.
Conference Reports
Christina Lau, 26 Jun 2017

Feelings of injustice and low socioeconomic status can have a significant impact on disease severity in patients with fibromyalgia, according to data from a large survey presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

Jackey Suen, 23 Jun 2017

The fully-human immunocytokine dekavil (also known as F8-IL10) has demonstrated signs of safety and efficacy in patients with active rheumatoid arthritis (RA) in a phase I study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017.

Dr. Joseph Delano Fule Robles, 23 Jun 2017

Vobarilizumab, a nanobody consisting of an anti-interleukin 6 (IL-6) receptor domain developed for the treatment of rheumatoid arthritis (RA), is shown to be safe and efficacious in RA patients with inadequate response to methotrexate in a study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

Elaine Tan, 22 Jun 2017

Women who are overweight or obese, as defined by a high body mass index (BMI), abdominal obesity and a higher body fat percentage, have a higher risk of developing rheumatoid arthritis (RA), results of a Danish population cohort study has shown.

Dr. Joseph Delano Fule Robles, 22 Jun 2017

Ixekizumab, a high-affinity monoclonal antibody targeting interleukin-17A (IL-17A), has demonstrated safety and efficacy in patients with psoriatic arthritis resistant to tumour necrosis factor (TNF) inhibitor therapy in a study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

Christina Lau, 21 Jun 2017

Denosumab brings greater gains in spine and hip bone mineral density (BMD) than risedronate in glucocorticoid-treated patients at risk of osteoporotic fracture, according to results of a phase III study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 in Madrid, Spain.

Dr. Joseph Delano Fule Robles, 21 Jun 2017

A novel serum autoantibody test and nail capillaroscopy have been shown to be useful for the diagnosis of early scleroderma, according to results of two studies presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.